Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer

DNA Repair (Amst). 2021 Jun:102:103103. doi: 10.1016/j.dnarep.2021.103103. Epub 2021 Mar 26.

Abstract

At the cellular level, DNA repair mechanisms are crucial in maintaining both genomic integrity and stability. DNA damage appears to be a central culprit in tumor onset and progression. Cyclin-dependent kinases (CDKs) and their regulatory partners coordinate the cell cycle progression. Aberrant CDK activity has been linked to a variety of cancers through deregulation of cell-cycle control. Besides DNA damaging agents and chromosome instability (CIN), disruptions in the levels of cell cycle regulators including cyclin-dependent kinase inhibitors (CDKIs) would result in unscheduled proliferation and cell division. The INK4 and Cip/Kip (CDK interacting protein/kinase inhibitor protein) family of CDKI proteins are involved in cell cycle regulation, transcription regulation, apoptosis, and cell migration. A thorough understanding of how these CDKIs regulate the DNA damage response through multiple signaling pathways may provide an opportunity to design efficient treatment strategies to inhibit carcinogenesis.

Keywords: Cell cycle; Cyclin-dependent kinase inhibitors; DNA damage response.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Cycle*
  • Cyclin-Dependent Kinase Inhibitor Proteins / metabolism*
  • DNA Damage*
  • DNA Repair
  • DNA, Neoplasm / metabolism
  • Humans
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / physiopathology
  • Signal Transduction*

Substances

  • Cyclin-Dependent Kinase Inhibitor Proteins
  • DNA, Neoplasm